A human abuse potential study of oral Rexista

Trial Profile

A human abuse potential study of oral Rexista

Phase of Trial: Phase II

Latest Information Update: 26 Feb 2018

At a glance

  • Drugs Oxycodone (Primary)
  • Indications Pain
  • Focus Registrational; Therapeutic Use
  • Sponsors Intellipharmaceutics International
  • Most Recent Events

    • 26 Feb 2018 Patient gender and indication assumed.
    • 26 Feb 2018 New trial record
    • 19 Feb 2018 According to a an Intellipharmaceutics media release, this trial is expected to provide additional data to support the oral route of abuse-deterrent labeling claims for Rexista.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top